In-Center Hemodialysis Six Times per Week versus Three Times per Week

被引:780
作者
Chertow, Glenn M. [1 ,2 ]
Levin, Nathan W. [3 ]
Beck, Gerald J. [4 ]
Depner, Thomas A. [5 ]
Eggers, Paul W. [6 ]
Gassman, Jennifer J. [4 ]
Gorodetskaya, Irina [1 ,2 ]
Greene, Tom [4 ,7 ]
James, Sam [2 ]
Larive, Brett [4 ]
Lindsay, Robert M. [8 ]
Mehta, Ravindra L. [9 ]
Miller, Brent [10 ]
Ornt, Daniel B. [11 ]
Rajagopalan, Sanjay [12 ]
Rastogi, Anjay [13 ]
Rocco, Michael V. [14 ]
Schiller, Brigitte [1 ,15 ]
Sergeyeva, Olga [3 ]
Schulman, Gerald [16 ]
Ting, George O. [1 ,17 ]
Unruh, Mark L. [18 ]
Star, Robert A. [6 ]
Kliger, Alan S. [19 ,20 ]
机构
[1] Stanford Univ, Palo Alto, CA 94304 USA
[2] Univ Calif San Francisco, San Francisco, CA 94143 USA
[3] Renal Res Inst, New York, NY USA
[4] Cleveland Clin Fdn, Cleveland, OH USA
[5] Univ Calif Davis, Davis, CA 95616 USA
[6] NIDDK, Bethesda, MD USA
[7] Univ Utah, Salt Lake City, UT USA
[8] Univ Western Ontario, London, ON, Canada
[9] Univ Calif San Diego, La Jolla, CA 92093 USA
[10] Washington Univ, St Louis, MO 63130 USA
[11] Case Western Reserve Univ, Cleveland, OH 44106 USA
[12] Ohio State Univ, Columbus, OH 43210 USA
[13] Univ Calif Los Angeles, Los Angeles, CA USA
[14] Wake Forest Univ, Winston Salem, NC 27109 USA
[15] Satellite Healthcare, San Jose, CA USA
[16] Vanderbilt Univ, Nashville, TN USA
[17] El Camino Hosp, Mountain View, CA USA
[18] Univ Pittsburgh, Pittsburgh, PA USA
[19] Hosp St Raphael, New Haven, CT 06511 USA
[20] Yale Univ, New Haven, CT USA
基金
美国国家卫生研究院;
关键词
LEFT-VENTRICULAR HYPERTROPHY; QUALITY-OF-LIFE; STAGE RENAL-DISEASE; CONVENTIONAL HEMODIALYSIS; NOCTURNAL HEMODIALYSIS; BLOOD-PRESSURE; LONG-TERM; FOLLOW-UP; MORTALITY; UREA;
D O I
10.1056/NEJMoa1001593
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND In this randomized clinical trial, we aimed to determine whether increasing the frequency of in-center hemodialysis would result in beneficial changes in left ventricular mass, self-reported physical health, and other intermediate outcomes among patients undergoing maintenance hemodialysis. METHODS Patients were randomly assigned to undergo hemodialysis six times per week (frequent hemodialysis, 125 patients) or three times per week (conventional hemodialysis, 120 patients) for 12 months. The two coprimary composite outcomes were death or change (from baseline to 12 months) in left ventricular mass, as assessed by cardiac magnetic resonance imaging, and death or change in the physical-health composite score of the RAND 36-item health survey. Secondary outcomes included cognitive performance; self-reported depression; laboratory markers of nutrition, mineral metabolism, and anemia; blood pressure; and rates of hospitalization and of interventions related to vascular access. RESULTS Patients in the frequent-hemodialysis group averaged 5.2 sessions per week; the weekly standard Kt/V-urea (the product of the urea clearance and the duration of the dialysis session normalized to the volume of distribution of urea) was significantly higher in the frequent-hemodialysis group than in the conventional-hemodialysis group (3.54 +/- 0.56 vs. 2.49 +/- 0.27). Frequent hemodialysis was associated with significant benefits with respect to both coprimary composite outcomes (hazard ratio for death or increase in left ventricular mass, 0.61; 95% confidence interval [CI], 0.46 to 0.82; hazard ratio for death or a decrease in the physical-health composite score, 0.70; 95% CI, 0.53 to 0.92). Patients randomly assigned to frequent hemodialysis were more likely to undergo interventions related to vascular access than were patients assigned to conventional hemodialysis (hazard ratio, 1.71; 95% CI, 1.08 to 2.73). Frequent hemodialysis was associated with improved control of hypertension and hyperphosphatemia. There were no significant effects of frequent hemodialysis on cognitive performance, self-reported depression, serum albumin concentration, or use of erythropoiesis-stimulating agents. CONCLUSIONS Frequent hemodialysis, as compared with conventional hemodialysis, was associated with favorable results with respect to the composite outcomes of death or change in left ventricular mass and death or change in a physical-health composite score but prompted more frequent interventions related to vascular access.
引用
收藏
页码:2287 / 2300
页数:14
相关论文
共 39 条
[1]   Effects of short daily versus conventional hemodialysis on left ventricular hypertrophy and inflammatory markers:: A prospective, controlled study [J].
Ayus, JC ;
Mizani, MR ;
Achinger, SG ;
Thadhani, R ;
Go, AS ;
Lee, SK .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (09) :2778-2788
[2]   Darbepoetin alpha in lower-than-equimolar doses maintains haemoglobin levels in stable haemodialysis patients converting from epoetin alpha/beta [J].
Bock, H. Andreas ;
Hirt-Minkowski, Patricia ;
Bruenisholz, Michel ;
Keusch, Gerald ;
Rey, Simone ;
von Albertini, Beat .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2008, 23 (01) :301-308
[3]  
Buoncristiani U, 1988, Kidney Int Suppl, V24, pS137
[4]   Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life - A randomized controlled trial [J].
Culleton, Bruce F. ;
Walsh, Michael ;
Klarenbach, Scott W. ;
Mortis, Garth ;
Scott-Douglas, Narine ;
Quinn, Robert R. ;
Tonelli, Marcello ;
Donnelly, Sarah ;
Friedrich, Matthias G. ;
Kumar, Andreas ;
Mahallati, Houman ;
Hemmelgarn, Brenda R. ;
Manns, Braden J. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 298 (11) :1291-1299
[5]   Standard Kt/Vurea: a method of calculation that includes effects of fluid removal and residual kidney clearance [J].
Daugirdas, John T. ;
Depner, Thomas A. ;
Greene, Tom ;
Levin, Nathan W. ;
Chertow, Glenn M. ;
Rocco, Michael V. .
KIDNEY INTERNATIONAL, 2010, 77 (07) :637-644
[6]  
DAUGIRDAS SURI, 2004, HEMO STUDY J AM SOC, V15, P194
[7]  
DePalma John R, 2004, Hemodial Int, V8, P19, DOI 10.1111/j.1492-7535.2004.00082.x
[8]   Dialysis dose and the effect of gender and body size on outcome in the HEMO Study [J].
Depner, T ;
Daugirdas, J ;
Greene, T ;
Allon, M ;
Beck, G ;
Chumlea, C ;
Delmez, J ;
Gotch, F ;
Kusek, J ;
Levin, N ;
Macon, E ;
Milford, E ;
Owen, W ;
Star, R ;
Toto, R ;
Eknoyan, G .
KIDNEY INTERNATIONAL, 2004, 65 (04) :1386-1394
[9]   Daily hemodialysis efficiency: An analysis of solute kinetics [J].
Depner, TA .
ADVANCES IN RENAL REPLACEMENT THERAPY, 2001, 8 (04) :227-235
[10]   Effect of dialysis dose and membrane flux in maintenance hemodialysis. [J].
Eknoyan, G ;
Beck, GJ ;
Cheung, AK ;
Daugirdas, JT ;
Greene, T ;
Kusek, JW ;
Allon, M ;
Bailey, J ;
Delmez, JA ;
Depner, TA ;
Dwyer, JT ;
Levey, AS ;
Levin, NW ;
Milford, E ;
Ornt, DB ;
Rocco, MV ;
Schulman, G ;
Schwab, SJ ;
Teehan, BP ;
Toto, R .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (25) :2010-2019